Russell Investments Group
CAI

Russell Investments Group’s Caris Life Sciences CAI Stock Holding History

Russell Investments Group’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$752K Buy
42,199
+16,930
+67% +$303K ﹤0.01% 2599
2026
Q1 		$452K Buy
25,269
+23,274
+1,167% +$509K ﹤0.01% 2540
2025
Q4 		$53.8K Hold
1,995
– – ﹤0.01% 3273
2025
Q3 		$60.3K Buy
+1,995
New +$63.6K ﹤0.01% 3204

Other funds holding CAI

JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $27.2B AUM 43.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Russell Investments Group's CAI Position: Q2 2026 in Review

Russell Investments Group increased its Caris Life Sciences (CAI) stake by 67% in Q2 2026, buying an estimated $303K and bringing the position to 42,199 shares worth $752K. The position accounts for ﹤0.01% of the portfolio, ranked #2599.

Russell Investments Group first reported a position in CAI in Q3 2025 and has held it in 4 quarters since. 164 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Russell Investments Group held 42,199 shares of Caris Life Sciences worth $752K as of Q2 2026.
  • Russell Investments Group bought 16,930 Caris Life Sciences shares in Q2 2026, an estimated $303K.
  • Caris Life Sciences made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2599 holding.
  • Russell Investments Group first reported a position in Caris Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 164 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.